Literature DB >> 9036876

K-ras and p53 mutations in hereditary non-polyposis colorectal cancers.

L Losi1, M Ponz de Leon, J Jiricny, C Di Gregorio, P Benatti, A Percesepe, R Fante, L Roncucci, M Pedroni, J Benhattar.   

Abstract

Genetic instability related to defective DNA mismatch repair genes may be involved in the pathogenesis of carcinoma in Hereditary Non-Polyposis Colorectal Cancer (HNPCC). To test that the targets of genetic instability could include critical transforming genes involved in colon tumor progression, we examined 23 colorectal carcinomas in patients with HNPCC in order to detect somatic mutations in K-ras and p53 genes. Using single strand conformation polymorphism followed by direct DNA sequencing, we detected 4 mutations in K-ras gene (17%) and 3 in p53 gene (13%) which change the amino acid sequence of the protein p53. This is significantly lower than in sporadic cancer. Our data suggest that colon cancer in HNPCC might partly involve a distinct pathogenetic mechanism that involves other genes than those altered in sporadic tumors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9036876     DOI: 10.1002/(sici)1097-0215(19970220)74:1<94::aid-ijc16>3.0.co;2-i

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Accelerated growth of intestinal tumours after radiation exposure in Mlh1-knockout mice: evaluation of the late effect of radiation on a mouse model of HNPCC.

Authors:  Yutaka Tokairin; Shizuko Kakinuma; Masami Arai; Mayumi Nishimura; Mieko Okamoto; Eisaku Ito; Makoto Akashi; Yoshio Miki; Tatsuyuki Kawano; Takehisa Iwai; Yoshiya Shimada
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

2.  Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide.

Authors:  G Marra; S D'Atri; C Corti; L Bonmassar; M S Cattaruzza; P Schweizer; K Heinimann; Z Bartosova; M Nyström-Lahti; J Jiricny
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

3.  No major difference in K-ras and p53 abnormalities in sporadic and hereditary nonpolyposis colorectal adenomas.

Authors:  D W Voskuil; E Kampman; W van Geloof; M Grubben; F Kok; G van Muijen; F Nagengast; H Vasen; P van't Veer
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

4.  The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas.

Authors:  X P Hao; I M Frayling; J G Sgouros; M Q Du; T C Willcocks; I C Talbot; I P M Tomlinson
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

5.  Early carcinogenic events in HNPCC adenomas: differences with sporadic adenomas.

Authors:  Fleur Elise Marie Rijcken; Jan Jacob Koornstra; Tineke van der Sluis; Ek Wytske Boersma-van; Jan H Kleibeuker; Harry Hollema
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

Review 6.  Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients.

Authors:  Kristen M Drescher; Poonam Sharma; Henry T Lynch
Journal:  Clin Dev Immunol       Date:  2010-06-10

7.  Accumulated clonal genetic alterations in familial and sporadic colorectal carcinomas with widespread instability in microsatellite sequences.

Authors:  T Fujiwara; J M Stolker; T Watanabe; A Rashid; P Longo; J R Eshleman; S Booker; H T Lynch; J R Jass; J S Green; H Kim; J Jen; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

8.  Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients.

Authors:  A S Soliman; M L Bondy; S A El-Badawy; N Mokhtar; S Eissa; S Bayoumy; I A Seifeldin; P S Houlihan; J R Lukish; T Watanabe; A O Chan; D Zhu; C I Amos; B Levin; S R Hamilton
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

9.  Extensive molecular screening for hereditary non-polyposis colorectal cancer.

Authors:  B Dieumegard; S Grandjouan; J C Sabourin; M L Le Bihan; I Lefrère; J P Pignon; P Rougier; P Lasser; J Bénard; D Couturier; B Bressac-de Paillerets
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.